Minoxidil remains the gold standard for treating hair loss, but new research shows these ingredients have strong potential.

Researchers at the University of Bath have developed a new technology that—for many patients—could make injections a thing of ...

The once-weekly injection, already approved in pediatric patients with GHD, offers convenience over daily injections.

The US Food and Drug Administration (FDA) has granted approval for Ascendis Pharma’s Skytrofa (lonapegsomatropin-tcgd, ...

Lonapegsomatropin is a pegylated prodrug of the human growth hormone, somatropin, administered as a subcutaneous injection once-weekly.